The program is operational at 27 sites currently and has expanded to include 50 patients/month. Information is available at a special site that was set up by Imclone (http://www.cetuximab.com).

Patients can learn how it works (at http://www.Imclone.com) and can get information on how to enter the expanded access program for patients that have exhausted all other treatment avenues at the cetuximab site. Cetuximab trials for those who have not exhausted treatment options are also listed

Eun-Ok Im, MPH, PhD, School of Nursing, University of Texas at Austin and her colleagues are conducting a study ultimately aiming at development of computer software to assist nurses' decision making on cancer pain. In the study, Internet survey and online forum discussions using a Web site (home-page) will be conducted to get information on cancer pain of cancer patients from diverse cultural groups.

You are being asked to participate in this study because you have been identified as online cancer patients aged at least 18 years who can read and write English and whose self-reported ethnic identity is Hispanic, non-Hispanic (N-H) White, N-H African-American, or N-H Asian.

Data will be collected from September 15, 2003 to December 31, 2005. Your involvement will be: (a) about 30 minutes are usually needed to complete the Internet survey questionnaire; and (b) online forums will be conducted for 7 months (6 months for 9 topics and 1 month for additional topics that the participants may add) if you agree to participate in an additional online forum discussion. Your participation is asynchronous (participants can visit the online forum site and read and post messages at their convenience). Methods for the data collection phase include an Internet survey among 400 cancer patients in the U.S. on the Internet and online forum discussions among four ethnically different online forum groups (30 members per group at the beginning).

Reimbursement for participation will be made by providing 10 dollars of gift certificate per Internet survey participant and 50 dollars of gift certificate per online forum participant. To get reimbursed for the online forums, at least two messages per topic should be posted. For more information, please visit at our Web-site (http://dscp.nur.utexas.edu/PAIN/) and/or contact us.

The study investigates treatment adherence behaviors and quality of life in colorectal cancer patients/survivors. Specifically, we examine the relationship of several variables to treatment adherence and quality of life: (a) marital relationship, (b) emotion regulation and mood, (c) treatment perceptions, and (d) self-efficacy. We intend to have both patients and their spouses/partners complete the on-line survey.

This study has been reviewed and given approval by the Office of Research Integrity at the University of Kentucky. The study is completely voluntary and totally anonymous. We do not ask respondents for any identifying information such as name, email address, etc. Individuals who log onto the site may quit at any time by simply closing their browser.

Description: This study is being conducted to compare the progression free survival in patients being treated with combination chemotherapy plus an investigational drug versus combination chemotherapy plus placebo. In order to participate in this trial, patients must: • be 18 years of age or older. • Have a confirmed diagnosis of cancer of the colon or rectum with metastatic disease. • be receiving chemotherapy treatment for the first time.

Description: This study is being conducted to determine the overall survival rates of patients with previously treated metastatic adenocarcinoma of the colon or rectum treated with chemotherapy plus an investigational drug versus patients treated with chemotherapy plus placebo. In order to participate in this trial, patients must: • be 18 years of age or older. • have a confirmed diagnosis of cancer of the colon or rectum with metastatic disease. • have been previously treated with chemotherapy.